Option Care Health (NASDAQ:OPCH) Rating Lowered to “Neutral” at Bank of America

Option Care Health (NASDAQ:OPCH) was downgraded by analysts at Bank of America from a “buy” rating to a “neutral” rating in a report released on Wednesday, Marketbeat.com reports. They currently have a $29.00 target price on the stock, down from their prior target price of $43.00. Bank of America‘s price objective points to a potential upside of 25.87% from the stock’s previous close.

A number of other research firms have also weighed in on OPCH. Barrington Research restated an “outperform” rating and set a $40.00 target price on shares of Option Care Health in a research note on Wednesday, October 23rd. JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th.

Option Care Health Stock Down 2.2 %

Shares of NASDAQ:OPCH opened at $23.04 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.76 and a quick ratio of 1.36. The firm has a market capitalization of $3.94 billion, a PE ratio of 19.36, a price-to-earnings-growth ratio of 2.31 and a beta of 1.29. The firm’s 50-day moving average is $30.65 and its two-hundred day moving average is $29.97. Option Care Health has a 1 year low of $22.84 and a 1 year high of $34.63.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.22 billion. Analysts predict that Option Care Health will post 1.22 EPS for the current year.

Insider Activity

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently modified their holdings of the company. Harbor Capital Advisors Inc. boosted its holdings in shares of Option Care Health by 317.9% during the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after purchasing an additional 73,312 shares during the last quarter. Comerica Bank boosted its holdings in shares of Option Care Health by 6.5% during the first quarter. Comerica Bank now owns 760,915 shares of the company’s stock worth $25,521,000 after purchasing an additional 46,639 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Option Care Health by 182.9% during the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after purchasing an additional 146,837 shares during the last quarter. Edgestream Partners L.P. boosted its holdings in shares of Option Care Health by 96.8% during the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after purchasing an additional 172,845 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of Option Care Health during the second quarter worth $973,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.